Hints and tips:
...Glaxo first bought Wellcome in 1995 and then SmithKline Beecham in 2000, becoming GSK. Glencore acquired Xstrata in 2013....
...SmithKline Beecham (now part of GSK) pulled its successful Lyme disease vaccine in the early 2000s amid rising anti-vaccine sentiment....
...Nor have Glaxo and SmithKline Beecham. Telecoms groups have long claimed they need mergers to compete — most recently in the US and Europe....
...Beecham to create GSK....
...A veteran of the pharmaceuticals industry, he experienced a big merger while working for SmithKline Beecham when it combined with Glaxo Wellcome in 2000....
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...He notes that Allergan was spun out of SmithKline in 1989 when it merged with Beecham....
...A Pfizer-AstraZeneca deal would rival the $74bn merger between GlaxoWellcome and SmithKline Beecham in 2000 as the biggest in industry history, and outstrip Pfizer’s own record $68bn acquisition of Wyeth...
...He was also finance director at BG Group and chief financial officer at SmithKline Beecham, which merged with Glaxo Wellcome in 2000 to createGlaxoSmithKline....
...GSK, formed by a merger between Glaxo Wellcome and SmithKline Beecham in 2000, knows size alone is no cure-all....
...In 1999, Smithkline Beecham held a 29 per cent stake in the group. Quest’s laboratories provide test for cancers, cardiovascular diseases, thyroid disorders, and infectious diseases....
International Edition